BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang Z, Sun X, Feng Y, Liu X, Zhou L, Sui H, Ji Q, E Q, Chen J, Wu L. Dihydromyricetin reverses MRP2-mediated MDR and enhances anticancer activity induced by oxaliplatin in colorectal cancer cells. Anticancer Drugs. 2017;28:281-288. [PMID: 27997436 DOI: 10.1097/cad.0000000000000459] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zheng J, Jiang Y, Huang X, Fang L. Neglected, Drug-Induced Platinum Accumulation Causes Immune Toxicity. Front Pharmacol 2020;11:1166. [PMID: 32903504 DOI: 10.3389/fphar.2020.01166] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lee GY, Lee JS, Son CG, Lee NH. Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines. Chin J Integr Med 2021;27:551-60. [PMID: 32740824 DOI: 10.1007/s11655-020-3425-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Myint K, Biswas R, Li Y, Jong N, Jamieson S, Liu J, Han C, Squire C, Merien F, Lu J, Nakanishi T, Tamai I, McKeage M. Identification of MRP2 as a targetable factor limiting oxaliplatin accumulation and response in gastrointestinal cancer. Sci Rep 2019;9:2245. [PMID: 30783141 DOI: 10.1038/s41598-019-38667-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Li H, Li Q, Liu Z, Yang K, Chen Z, Cheng Q, Wu L. The Versatile Effects of Dihydromyricetin in Health. Evid Based Complement Alternat Med 2017;2017:1053617. [PMID: 28947908 DOI: 10.1155/2017/1053617] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 5.8] [Reference Citation Analysis]
5 Lian G, Yuan J, Gao Y. In vitro Transport Ability of ABCC2 (G1249A) Polymorphic Variant Towards Anticancer Drugs. Onco Targets Ther 2020;13:1413-9. [PMID: 32110040 DOI: 10.2147/OTT.S207613] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Sui H, Duan P, Guo P, Hao L, Liu X, Zhang J, Zhu H, Zhao M, Wang H, Li Q, Wang S. Zhi Zhen Fang formula reverses Hedgehog pathway mediated multidrug resistance in colorectal cancer. Oncol Rep 2017;38:2087-95. [PMID: 28849164 DOI: 10.3892/or.2017.5917] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
7 Li Z, Ali I, Qiu J, Zhao H, Ma W, Bai A, Wang D, Li J. Eco-Friendly and Facile Synthesis of Antioxidant, Antibacterial and Anticancer Dihydromyricetin-Mediated Silver Nanoparticles. Int J Nanomedicine 2021;16:481-92. [PMID: 33500618 DOI: 10.2147/IJN.S283677] [Reference Citation Analysis]
8 Tan M, Jiang B, Wang H, Ouyang W, Chen X, Wang T, Dong D, Yi S, Yi J, Huang Y, Tang M, Xiao Y, Jiang Z, Zhou W. Dihydromyricetin induced lncRNA MALAT1-TFEB-dependent autophagic cell death in cutaneous squamous cell carcinoma. J Cancer 2019;10:4245-55. [PMID: 31413743 DOI: 10.7150/jca.32807] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
9 Biswas R, Bugde P, He J, Merien F, Lu J, Liu DX, Myint K, Liu J, McKeage M, Li Y. Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells. Cancers (Basel) 2019;11:E1330. [PMID: 31500349 DOI: 10.3390/cancers11091330] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chen YL, Zhang YL, Dai YC, Tang ZP. Systems pharmacology approach reveals the antiinflammatory effects of Ampelopsis grossedentata on dextran sodium sulfate-induced colitis. World J Gastroenterol 2018; 24(13): 1398-1409 [PMID: 29632421 DOI: 10.3748/wjg.v24.i13.1398] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
11 Ye L, Yin G, Jiang M, Tu B, Li Z, Wang Y. Dihydromyricetin Exhibits Antitumor Activity in Nasopharyngeal Cancer Cell Through Antagonizing Wnt/β-catenin Signaling. Integr Cancer Ther 2021;20:1534735421991217. [PMID: 33724059 DOI: 10.1177/1534735421991217] [Reference Citation Analysis]
12 Zhang Y, Huang X, Feng S, Chen C, Guo D, Fang L. Platinum Accumulation and Cancer-Related Fatigue, Correlation With IL-8, TNF-α and Hemocytes. Front Pharmacol 2021;12:658792. [PMID: 34557089 DOI: 10.3389/fphar.2021.658792] [Reference Citation Analysis]
13 Jiang L, Ye WC, Li Z, Yang Y, Dai W, Li M. Anticancer effects of dihydromyricetin on the proliferation, migration, apoptosis and in vivo tumorigenicity of human hepatocellular carcinoma Hep3B cells. BMC Complement Med Ther 2021;21:194. [PMID: 34229692 DOI: 10.1186/s12906-021-03356-5] [Reference Citation Analysis]
14 Fu ZY. Role of ATP-binding cassette transporters, apoptosis, and long non-coding RNAs in gastric cancer multidrug resistance. Shijie Huaren Xiaohua Zazhi 2017; 25(32): 2838-2850 [DOI: 10.11569/wcjd.v25.i32.2838] [Reference Citation Analysis]
15 Fan X, Zeng Y, Fan Z, Cui L, Song W, Wu Q, Gao Y, Yang D, Mao X, Zeng B, Zhang M, Ni Q, Li Y, Wang T, Li D, Yang M. Dihydromyricetin promotes longevity and activates the transcription factors FOXO and AOP in Drosophila. Aging (Albany NY) 2020;13:460-76. [PMID: 33291074 DOI: 10.18632/aging.202156] [Reference Citation Analysis]